TCIM
AVXL icon

TIAA CREF Investment Management’s Anavex Life Sciences AVXL Stock Holding History

TIAA CREF Investment Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-105,904
Closed -$292K – 3081
2018
Q1 		$292K Buy
105,904
+15,751
+17% +$44.5K ﹤0.01% 2907
2017
Q4 		$290K Sell
90,153
-6,823
-7% -$26.9K ﹤0.01% 2948
2017
Q3 		$401K Hold
96,976
– – ﹤0.01% 2923
2017
Q2 		$516K Sell
96,976
-29,562
-23% -$171K ﹤0.01% 2855
2017
Q1 		$726K Sell
126,538
-42,897
-25% -$222K ﹤0.01% 2658
2016
Q4 		$671K Buy
169,435
+51,264
+43% +$183K ﹤0.01% 2722
2016
Q3 		$429 Buy
118,171
+25,129
+27% +$106K ﹤0.01% 2914
2016
Q2 		$568K Buy
+93,042
New +$449K ﹤0.01% 2808

Other funds holding AVXL

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return